Table 4.

Total and proportion of total adverse reactions reported to the NHSN HM, reported at 30, 60, and 90 days following investigation at the facility, United States 2010–2016

	n/N	% of adverse reactions reported within 30 days	n/N	% of adverse reactions reported within 60 days	n/N	% of adverse reactions reported within 90 days
All facilities
2010	109/511	21.3%	193/511	37.8%	284/511	55.6%
2011	871/2568	33.9%	1488/2568	57.9%	1824/2568	71.0%
2012	1300/3363	38.7%	2212/3363	65.8%	2562/3363	76.2%
2013	1459/3462	42.1%	2397/3462	69.2%	2734/3462	79.0%
2014	1937/4743	40.8%	3241/4743	68.3%	3750/4743	79.1%
2015	1952/4733	41.2%	3228/4733	68.2%	3722/4733	78.6%
2016	2147/4453	48.2%	3331/4453	74.8%	3969/4453	89.1%
Massachusetts facilities
2010	6/23	26.1%	17/23	73.9%	23/23	100.0%
2011	47/186	25.3%	178/186	95.7%	185/186	99.5%
2012	62/280	22.1%	243/280	86.8%	261/280	93.2%
2013	92/332	27.7%	222/332	66.9%	238/332	71.7%
2014	413/1021	40.5%	750/1021	73.5%	780/1021	76.4%
2015	617/1181	52.2%	1006/1181	85.2%	1080/1181	91.4%
2016	862/1198	72.0%	1170/1198	97.7%	1187/1198	99.1%
Non-Massachusetts facilities
2010	103/488	21.1%	103/488	36.1%	261/488	53.5%
2011	824/2382	34.6%	824/2382	55.0%	1639/2382	68.8%
2012	1238/3083	40.2%	1238/3083	63.9%	2301/3083	74.6%
2013	1367/3130	43.7%	1367/3130	69.5%	2496/3130	79.7%
2014	1524/3722	40.9%	1524/3722	66.9%	2970/3722	79.8%
2015	1335/3552	37.6%	1335/3552	62.6%	2642/3552	74.4%
2016	1285/3255	39.5%	1285/3255	66.4%	2782/3255	85.5%

HM = Hemovigilance Module; NHSN = National Healthcare Safety Network.